DE102004016437A1 - Verfahren zur Erkennung von Signaturen in komplexen Genexpressionsprofilen - Google Patents

Verfahren zur Erkennung von Signaturen in komplexen Genexpressionsprofilen Download PDF

Info

Publication number
DE102004016437A1
DE102004016437A1 DE102004016437A DE102004016437A DE102004016437A1 DE 102004016437 A1 DE102004016437 A1 DE 102004016437A1 DE 102004016437 A DE102004016437 A DE 102004016437A DE 102004016437 A DE102004016437 A DE 102004016437A DE 102004016437 A1 DE102004016437 A1 DE 102004016437A1
Authority
DE
Germany
Prior art keywords
expression profile
expression profiles
complex
determining
biological sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE102004016437A
Other languages
English (en)
Inventor
Thomas Haeupl
Joachim Gruen
Andreas Radbruch
Gerd-Ruediger Burmester
Christian Kaps
Andreas Gruetzkau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OLIGENE GmbH
Original Assignee
OLIGENE GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OLIGENE GmbH filed Critical OLIGENE GmbH
Priority to DE102004016437A priority Critical patent/DE102004016437A1/de
Priority to PCT/EP2005/003520 priority patent/WO2005095644A2/de
Priority to EP05716523A priority patent/EP1733050A2/de
Priority to US11/547,040 priority patent/US20080108509A1/en
Publication of DE102004016437A1 publication Critical patent/DE102004016437A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection

Abstract

Die vorliegende Erfindung betrifft ein Verfahren zur Erkennung von Signaturen in komplexen Genexpressionsprofilen, das die Schritte umfaßt von: a) zur Verfügung stellen einer zu untersuchenden biologischen Probe, b) zur Verfügung stellen mindestens eines geeigneten Expressionsprofils, wobei das mindestens eine Expressionsprofil einen oder mehrere Marker umfaßt, die ausschließlich für das Expressionsprofil typisch sind, c) Bestimmen des komplexen Expressionsprofils der biologischen Probe, d) Bestimmen der quantitativen zellulären Zusammensetzung der biologischen Probe mittels der in den Schritten b) und c) bestimmten Expressionsprofile. Weiterhin kann das erfindungsgemäße Verfahren die Schritte von e) Berechnung eines virtuellen Signals, das aufgrund der bestimmten Zusammensetzung der Expressionsprofile erwartet wird, f) Berechnung der Differenz aus dem tatsächlichen gemessenen komplexen Expressionsprofil und dem virtuellen Signal und g) Bestimmen der quantitativen Zusammensetzung des komplexen Expressionsprofils auf Basis der ermittelten Differenzen umfassen. Die vorliegende Erfindung betrifft weiterhin die Anwendung des erfindungsgemäßen Verfahrens in der Diagnose, Prognose und/oder Verfolgung einer Erkrankung. Schließlich werden entsprechende Computersysteme, Computerprogramme, computerlesbare Datenträgermedien und Laborroboter oder Auswertegeräte für molekulare Nachweismethoden offenbart.
DE102004016437A 2004-04-04 2004-04-04 Verfahren zur Erkennung von Signaturen in komplexen Genexpressionsprofilen Ceased DE102004016437A1 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE102004016437A DE102004016437A1 (de) 2004-04-04 2004-04-04 Verfahren zur Erkennung von Signaturen in komplexen Genexpressionsprofilen
PCT/EP2005/003520 WO2005095644A2 (de) 2004-04-04 2005-04-04 Verfahren zur erkennung von signaturen in komplexen genexpressionsprofilen
EP05716523A EP1733050A2 (de) 2004-04-04 2005-04-04 Verfahren zur erkennung von signaturen in komplexen genexpressionsprofilen
US11/547,040 US20080108509A1 (en) 2004-04-04 2005-04-04 Process for Recognizing Signatures in Complex Gene Expression Profiles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004016437A DE102004016437A1 (de) 2004-04-04 2004-04-04 Verfahren zur Erkennung von Signaturen in komplexen Genexpressionsprofilen

Publications (1)

Publication Number Publication Date
DE102004016437A1 true DE102004016437A1 (de) 2005-10-20

Family

ID=34979107

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102004016437A Ceased DE102004016437A1 (de) 2004-04-04 2004-04-04 Verfahren zur Erkennung von Signaturen in komplexen Genexpressionsprofilen

Country Status (4)

Country Link
US (1) US20080108509A1 (de)
EP (1) EP1733050A2 (de)
DE (1) DE102004016437A1 (de)
WO (1) WO2005095644A2 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008066878A2 (en) * 2006-11-29 2008-06-05 University Of Vermont And State Agricultural College Methods and products for diagnosing cancer
US8445442B2 (en) 2007-04-26 2013-05-21 University Of Vermont And State Agricultural College CCL18 and CCL3 methods and compositions for detecting and treating cancer
GB0722582D0 (en) * 2007-11-16 2007-12-27 Secr Defence Early detection of sepsis
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
WO2010032816A1 (ja) * 2008-09-19 2010-03-25 小野薬品工業株式会社 新規リゾホスファチジルセリン受容体
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
CN104195227B (zh) * 2008-11-07 2017-04-12 适应生物技术公司 通过序列分析监测状况的方法
US8691510B2 (en) * 2008-11-07 2014-04-08 Sequenta, Inc. Sequence analysis of complex amplicons
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US8748103B2 (en) * 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
EP2387627B1 (de) 2009-01-15 2016-03-30 Adaptive Biotechnologies Corporation Adaptive immunitätsprofilierung und verfahren zur erzeugung monoklonaler antikörper
EP2435580A2 (de) * 2009-05-29 2012-04-04 The Regents of the University of California Mit toleranz bei transplantatempfängern assoziierte b-zellen-signatur
RU2539032C2 (ru) 2009-06-25 2015-01-10 Фред Хатчинсон Кансэр Рисёч Сентер Способ измерения искусственного иммунитета
CA2772929A1 (en) 2009-09-03 2011-03-11 Genentech, Inc. Methods for treating, diagnosing, and monitoring rheumatoid arthritis
US9043160B1 (en) 2009-11-09 2015-05-26 Sequenta, Inc. Method of determining clonotypes and clonotype profiles
EP2385134A1 (de) * 2010-05-07 2011-11-09 Ludwig-Maximilians-Universität München Risikoprognoseverfahren für chronische lymphatische Leukämie
EP2596116A4 (de) * 2010-07-23 2014-03-19 Harvard College Verfahren zur erkennung von autoimmun- oder autoimmunbezogenen erkrankungen oder leiden
EP2596117B1 (de) * 2010-07-23 2017-12-27 President and Fellows of Harvard College Verfahren zur erkennung von niergenbezogenen erkrankungen oder leiden
WO2012012717A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
AU2012325791B2 (en) 2011-10-21 2018-04-05 Adaptive Biotechnologies Corporation Quantification of adaptive immune cell genomes in a complex mixture of cells
CA2858070C (en) 2011-12-09 2018-07-10 Adaptive Biotechnologies Corporation Diagnosis of lymphoid malignancies and minimal residual disease detection
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
ES2662128T3 (es) 2012-03-05 2018-04-05 Adaptive Biotechnologies Corporation Determinación de cadenas de receptor inmunitario emparejadas a partir de la frecuencia de subunidades coincidentes
ES2582554T3 (es) 2012-05-08 2016-09-13 Adaptive Biotechnologies Corporation Composiciones y método para medir y calibrar el sesgo de la amplificación en reacciones de PCR multiplexadas
EP2875356A1 (de) * 2012-07-23 2015-05-27 INSERM - Institut National de la Santé et de la Recherche Médicale Verfahren zur diagnose von sklerodermie
CA2886647A1 (en) 2012-10-01 2014-04-10 Adaptive Biotechnologies Corporation Immunocompetence assessment by adaptive immune receptor diversity and clonality characterization
EP4202441A3 (de) 2013-03-09 2023-07-26 Immunis.AI, Inc. Genexpressionsprofil in makrophagen zur diagnose von krebs
WO2014170497A2 (en) * 2013-04-19 2014-10-23 Epiontis Gmbh Method for identifying the quantitative cellular composition in a biological sample
US9708657B2 (en) 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
CA2941612A1 (en) 2014-03-05 2015-09-11 Adaptive Biotechnologies Corporation Methods using randomer-containing synthetic molecules
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
ES2777529T3 (es) 2014-04-17 2020-08-05 Adaptive Biotechnologies Corp Cuantificación de genomas de células inmunitarias adaptativas en una mezcla compleja de células
US10392663B2 (en) 2014-10-29 2019-08-27 Adaptive Biotechnologies Corp. Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from a large number of samples
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
EP3224384A4 (de) 2014-11-25 2018-04-18 Adaptive Biotechnologies Corp. Charakterisierung von adaptiver immunreaktion auf impfungen oder infektionen unter verwendung von immunrepertoiresequenzierung
ES2858306T3 (es) 2015-02-24 2021-09-30 Adaptive Biotechnologies Corp Método para determinar el estado de HLA mediante secuenciación del repertorio inmunitario
WO2016161273A1 (en) 2015-04-01 2016-10-06 Adaptive Biotechnologies Corp. Method of identifying human compatible t cell receptors specific for an antigenic target
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
WO2023222927A2 (en) * 2022-05-20 2023-11-23 Novigenix Sa Biomarkers for colorectal neoplasia

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003072065A2 (en) * 2002-02-28 2003-09-04 Iconix Pharmaceuticals, Inc. Drug signatures
WO2003083141A1 (en) * 2002-03-29 2003-10-09 Arcturus Engineering, Inc. Interpreting cytological specimens via molecular histological signatures
WO2004005882A2 (en) * 2001-06-18 2004-01-15 Psychiatric Genomics, Inc. Multi-parameter high throughput screening assays (mphts)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030104394A1 (en) * 2001-12-03 2003-06-05 Xudong Dai Method and system for gene expression profiling analysis utilizing frequency domain transformation
DE10159404A1 (de) * 2001-12-04 2003-06-26 Arevia Gmbh Verfahren zur Analyse von Gewebeproben
EP1627083A2 (de) * 2003-05-07 2006-02-22 Agilent Technologies, Inc. Systeme und verfahren zur bestimmung der zelltypzusammensetzung von gemischten zellpopulationen unter verwendung von genexpressions-signaturen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004005882A2 (en) * 2001-06-18 2004-01-15 Psychiatric Genomics, Inc. Multi-parameter high throughput screening assays (mphts)
WO2003072065A2 (en) * 2002-02-28 2003-09-04 Iconix Pharmaceuticals, Inc. Drug signatures
WO2003083141A1 (en) * 2002-03-29 2003-10-09 Arcturus Engineering, Inc. Interpreting cytological specimens via molecular histological signatures

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KIM, S. u.a.: Identification of combination gene sets for glioma classification. Mol. Cancer Ther. (2002) 1 (13) 1229-36 *
TÜRECI, Ö. u.a.: Computational dissection of tissue contamination for identification of colon cancer-specific expression profiles. FASEB J. (2003) 17 (3) 376-85 *
VENET, D. u.a.: Separation of samples into their constituents using gene expression data. Bioinfor-matics (2001) 17 (Suppl. 1) 279-87 *

Also Published As

Publication number Publication date
EP1733050A2 (de) 2006-12-20
WO2005095644A3 (de) 2006-04-13
WO2005095644A2 (de) 2005-10-13
US20080108509A1 (en) 2008-05-08

Similar Documents

Publication Publication Date Title
DE102004016437A1 (de) Verfahren zur Erkennung von Signaturen in komplexen Genexpressionsprofilen
Staals et al. Total MRI load of cerebral small vessel disease and cognitive ability in older people
Agbor-Enoh et al. Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation
López-Goñi et al. Predictive validity of the EuropASI: Clinical diagnosis or composite scoring?
EP1715333A3 (de) Verfahren zur Signalauslesung an einem gassensitiven Feldeffekttransistor
WO2011079938A3 (en) System and method for determining the concentration of an analyte in a sample fluid
EP2770328A3 (de) Verfahren zur Diagnose von Bauchspeicheldrüsenkrebs
JP2010525332A5 (de)
WO2006126008A3 (en) Improved immunoassay methods
BR112012019542A2 (pt) "método para avaliar o estado renal em um indivíduo, medição de um ou mais biomarcadores, e, kit"
AT514311A5 (de) Verfahren zum Identifizieren einer Teilmenge von Polynucleotiden aus einer dem Humangenom entsprechenden Ausgangsmenge von Polynucleotiden zur in vitro Bestimmung eines Schweregrads der Wirtsantwort eines Patienten
EP1215495A3 (de) Verfahren zur Erhöhung der klinischen Spezifität bei der Detektion von Tumoren und ihren Vorstufen durch simultane Messung von mindestens zwei verschiedenen molekularen Markern
Chung et al. Effect of renal function on serum cardiac troponin T—population and individual effects
CN106447040A (zh) 基于异类多传感器数据融合的机械设备健康状态评估方法
EP2671505A3 (de) Verfahren und Analysegerät zur Messung einer Hornhaut
de Carvalho et al. Sensitivity of MUP parameters in detecting change in early ALS
Franco et al. Can a quantitative means be used to predict flow patterns: agreement between visual inspection vs. flow index derived flow patterns
NZ592819A (en) Thyroid analyte detection and measurement
EP1215475A3 (de) Verfahren zum Überprüfen der Bremse eines Elektromotors
CN103293250B (zh) 糖尿病肾病诊断试剂盒及其应用
EP1785889A3 (de) Bestimmung der Reaktivität mittels EEG Analyse
Colon-Franco et al. Validation of a hand-held point of care device for lactate in adult and pediatric patients using traditional and locally-smoothed median and maximum absolute difference curves
ATE550668T1 (de) Verfahren zur identifizierung von patienten mit erhöhtem risiko für ein unerwünschtes herz- kreislauf-ereignis
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
DE60306328D1 (de) Verfahren zur integrierten Integritätsbewertung und Analyse von Nukleinsäuren

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8131 Rejection